Oleandrigenin-Derived Androstane Demonstrates Selective Antiproliferative Activity in Prostate Cancer Cells
An in vitro investigation shows that an oleandrigenin-derived androstane selectively suppresses prostate cancer cell proliferation and modulates androgen receptor signaling.










